£95.63

Springer Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Price data last checked 46 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 45 days • 45 data points (No recent data available)

Historical
Generating forecast...
£108.10 £94.38 £97.38 £100.37 £103.36 £106.35 £109.35 25 January 2026 05 February 2026 16 February 2026 27 February 2026 10 March 2026

Price Distribution

Price distribution over 45 days • 2 price levels

Days at Price
Current Price
34 days · current 11 days 0 9 17 26 34 £96 £108 Days at Price

Price Analysis

Most common price: £96 (34 days, 75.6%)

Price range: £96 - £108

Price levels: 2 different prices over 45 days

Description

Product Description        The specific topic, “Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants – New Perspectives In Parkinson`S Disease Therapy,” was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson`s disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): ß-carbolines (BCs) and tetrahydroisoquinolines  (TIQs). These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurorestorative, anticonvulsant and antiaddictive, substances.             In this book we are going to summarize, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of TIQs and BCs effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties. Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility of their therapeutic applications in neurodegenerative diseases such as Parkinson's disease. From the Back Cover This book summarizes, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of tetrahydroisoquinolines (TIQs) and beta-carbolines (BCs) effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties.  Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility of their therapeutic applications in neurodegenerative diseases such as Parkinson's disease. The specific topic, Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants – New Perspectives In Parkinson's Disease Therapy, was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson's disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): BCs and TIQs. These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively, and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurore

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
06 December 2011
Listed Since
03 August 2011

Barcode

No barcode data available

Similar Products You Might Like

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)
99% match

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Springer

£82.66 19 Dec 2025
Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)
94% match

Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)

£139.49 07 Jan 2026
The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)
94% match

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Springer

£110.89 11 Feb 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
94% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Academic Press

£105.16 24 Feb 2026
Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease
94% match

Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease

Springer

£130.25 06 Feb 2026
Environmental Factors in Neurodegenerative Diseases (Volume 1) (Advances in Neurotoxicology, Volume 1)
93% match

Environmental Factors in Neurodegenerative Diseases (Volume 1) (Advances in Neurotoxicology, Volume 1)

Academic Press

£128.99 09 Mar 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
93% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Academic Press

£101.49 14 Apr 2026
Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
93% match

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Academic Press

£90.29 28 Mar 2026
Excitotoxicity in Neurological Diseases: New Therapeutic Challenge
93% match

Excitotoxicity in Neurological Diseases: New Therapeutic Challenge

Springer

£110.66 08 Jan 2026
Neurotoxic Factors in Parkinson’s Disease and Related Disorders
93% match

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

Springer

£107.43 01 Mar 2026
Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects
93% match

Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects

Academic Press

£101.99 07 Mar 2026
Neurotoxicity of Drugs of Abuse: Volume 8 (Advances in Neurotoxicology, Volume 8)
93% match

Neurotoxicity of Drugs of Abuse: Volume 8 (Advances in Neurotoxicology, Volume 8)

Academic Press

£128.99 28 Feb 2026
Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76
93% match

Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76

Academic Press

£152.67 11 Mar 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
93% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Natural Products and Neuroprotection
93% match

Natural Products and Neuroprotection

MDPI AG

£54.50 21 Feb 2026
Environmental Contaminants and Neurological Disorders (Emerging Contaminants and Associated Treatment Technologies)
93% match

Environmental Contaminants and Neurological Disorders (Emerging Contaminants and Associated Treatment Technologies)

Springer

£113.02 09 Mar 2026
Neuroprotective Agents: Seventh International Conference, Volume 1053 (Annals of the New York Academy of Sciences)
93% match

Neuroprotective Agents: Seventh International Conference, Volume 1053 (Annals of the New York Academy of Sciences)

Wiley-Blackwell

£92.85 27 Feb 2026
Protein Chaperones and Protection from Neurodegenerative Diseases (Wiley Series in Protein and Peptide Science)
93% match

Protein Chaperones and Protection from Neurodegenerative Diseases (Wiley Series in Protein and Peptide Science)

Wiley

£111.49 13 Apr 2026
Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)
93% match

Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)

Springer

£98.00 15 Jan 2026
Handbook of Neurotoxicology: Volume I: 1
93% match

Handbook of Neurotoxicology: Volume I: 1

Humana

£149.99 08 Mar 2026
Run in the Light: Exploring Exercise and Photobiomodulation in Parkinson's Disease (Iop Series in Photomedicine and Biophotonics)
93% match

Run in the Light: Exploring Exercise and Photobiomodulation in Parkinson's Disease (Iop Series in Photomedicine and Biophotonics)

Morgan & Claypool

£64.70 08 Mar 2026
Recent Advances in Parkinsons Disease: Part I: Basic Research (Progress in Brain Research): Volume 183
93% match

Recent Advances in Parkinsons Disease: Part I: Basic Research (Progress in Brain Research): Volume 183

Elsevier

£152.25 10 Mar 2026
Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders
93% match

Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders

Academic Press

£165.49 30 Jan 2026
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
93% match

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Humana

£148.66 08 Mar 2026